ClinicalTrials.Veeva

Menu

IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism

H

Hospital General Ajusco Medio

Status

Completed

Conditions

Secondary Hyperparathyroidism

Treatments

Diagnostic Test: Intraoperative Paratohormone

Study type

Observational

Funder types

Other

Identifiers

NCT04484116
Not assigned

Details and patient eligibility

About

Secondary hyperparathyroidism (SHPT) is a multisystemic syndrome that affects calcium and bone homeostasis in patients with chronic kidney disease (CKD). Despite medical treatment, 1-2% of patients require parathyroidectomy anually. The use of an intraoperative paratohormone protocol (IOPTH) to predict cure still in debate, due to the lack of standardized protocols, the use of different assays and uneven PTH clearance. The aim of this study was to determine the diagnostic accuracy of an IOPTH in patients with SHPT for predicting successful surgery after parathyroidectomy.

Full description

A prospective observational study (cohort) was performed in patients who were submitted to parathyroidectomy by an endocrine surgeon for SHPT. All were submitted to a bilateral neck exploration with a subtotal parathyroidectomy. Three IOPTH determinations were withdrawn: at anesthetic induction (PTH0), 15 minutes (PTH15), and 30 minutes (PTH30) after completion gland resection. Another sample was taken 24 hours after the procedure (PTH24), values <150pg/mL defined a successful surgery and patients were assigned to the successful or unsuccessful group. IOPTH drop was analyzed to predict successful surgery with drops of 70% and 90% at 15 and 30 minutes.

Enrollment

30 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • PTH >800pg/mL and SHPT symptoms, or
  • Asymptomatic patients with PTH >1000pg/mL who were resistant to treatment
  • compliance with the signature of the informed consent

Exclusion criteria

  • patients who respond adequately to medical treatment
  • incomplete IOPTH protocol

Trial design

30 participants in 2 patient groups

Succesful surgery
Description:
PTH 24 hours after surgery \<150pg/mL
Treatment:
Diagnostic Test: Intraoperative Paratohormone
Unsuccessful surgery
Description:
PTH 24 hours after surgery \>150pg/mL
Treatment:
Diagnostic Test: Intraoperative Paratohormone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems